Circulatory biomarker: Higher circulatory levels of NEAT1 (151), LINK-A (237), and AWPPH (238), in addition to lower serum GASL1 levels (239), have shown considerable diagnostic value for glioma. This evidence concerns the gene NEAT1 and central nervous system cancer.